Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ypsomed Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Implanet SA Logo
Designs and sells advanced implants for orthopedic and spinal surgery to surgeons worldwide.
France
ALIMP
Implantica SDB Logo
Develops and commercializes advanced medical implants like RefluxStop™ for acid reflux disease.
Sweden
IMP
InBody Co., Ltd. Logo
Develops professional BIA body composition analyzers for medical, fitness, and research.
South Korea
041830
Inogen Inc Logo
Manufactures portable oxygen concentrators for homecare, enhancing patient mobility.
United States of America
INGN
Inspira Technologies OXY B.H.N. Ltd Logo
Develops respiratory tech to oxygenate blood, avoiding invasive mechanical ventilation.
United States of America
IINN
INSPIRATION HEALTHCARE GROUP PLC Logo
Develops medical technology for critical care, specializing in neonatal and infant life support.
United Kingdom
IHC
InspireMD, Inc. Logo
Develops an FDA-approved carotid stent system for stroke prevention in high-risk patients.
United States of America
NSPR
Integer Holdings Corp Logo
A medical device CDMO providing outsourcing for cardiac, neuro, and vascular technologies.
United States of America
ITGR
INTEGRA LIFESCIENCES HOLDINGS CORP Logo
A global medtech company for neurosurgery, regenerative tissue, and surgical solutions.
United States of America
IART
Integrum AB Logo
Develops bone-anchored implant systems for amputees to improve mobility and quality of life.
Sweden
INTEG

Talk to a Data Expert

Have a question? We'll get back to you promptly.